Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Futubull > Quotes > NNVC Nanoviricides > Detailed Quotes

NNVC Nanoviricides

Watchlist
1.890
+0.010+0.53%
Close 07/01 16:00 ET
1.89000.00%
Post Mkt Price 07/01 16:08 ET
Giving away premium quotes worth 5000 HKD/year to unlock more data
Get NOW
High
2.060
Open
2.060
Turnover
23.98K
Low
1.800
Pre Close
1.880
Volume
12.48K
Market Cap
21.84M
P/E(TTM)
Loss
52wk High
7.860
Shares
11.55M
P/E(Static)
Loss
52wk Low
1.040
Float Cap
20.64M
Bid/Ask %
-27.27%
Historical High
262.500
Shs Float
10.92M
Volume Ratio
0.42
Historical Low
1.040
Dividend TTM
--
Div Yield TTM
--
P/B
0.88
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.11%
Amplitude
13.83%
Avg Price
1.920
Lot Size
1
Float Cap
20.64M
Bid/Ask %
-27.27%
Historical High
262.500
Shs Float
10.92M
Volume Ratio
0.42
Historical Low
1.040
Dividend TTM
--
P/B
0.88
Dividend LFY
--
Turnover Ratio
0.11%
Amplitude
13.83%
Avg Price
1.920
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
NanoViricides, Inc., a nano-biopharmaceutical research and development company, discovers, develops, and commercializes drugs for the treatment of viral infections. The company develops Human Coronavirus Program for COVID-19 seasonal coronavirus affliction; HerpeCide Dermal Topical and Eye Drops for the treatment of shingles, PHN, chickenpox, herpes, recurrent herpes labialis, genital herpes, and ocular herpes keratitis; and HerpeCide IntraOcular Injection for viral acute retinal necrosis The company also develops FluCide Broad-Spectrum Anti-Influenza nanoviricide, which is injectable for hospitalized patients and oral for outpatients; Nanoviricide eye drops for viral diseases of the external eye; DengueCide for treatment of various types of Dengue viruses; and HIVCide, an escape-resistant anti-HIV nanoviricide. In addition, it develops other nanoviricides drug projects for treatment of different viruses and indications; and HerpeCide program expansion drug projects for different herpes viruses for different indications. NanoViricides, Inc. was founded in 2005 and is based in Shelton, Connecticut.
CEO: Diwan Ph.D., Anil R.
Market: AMEX
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist
Back to the Top